Form EFFECT Lexaria Bioscience Corp.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 13, 2026 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lexaria reports animal study results for drug delivery formulations
- Lexaria Announces Results from Animal Study GLP-1-A26-1
- Archimedes Tech SPAC Partners II Co. Announces Shareholder Approval of Proposed Business Combination with Forge Nano, Inc.
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share